Abcellera Biologics Inc ABCL

$12.48 -0.16 (-1.27%)

Valuation

Market cap
3,846,435,000
Revenue TTM
$75,130,000
Net income TTM
$-146,410,000
PE ratio
0.00
Forward PE
—
Profit margin
-194.88%
Debt to equity
0.00

Trading

Volume
1,552,308
Avg volume
7,197,830
Day's range
$12.20 – $12.72
Shares out
306,611,000
Stochastic %K
24%
Beta
1.41
Analysts
Strong Sell
Price target
$16.70

Price

Company profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-medi...

Show more

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc.; and Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 559 9005
Website
https://www.abcellera.com
Address
150 W 4th Avenue, Vancouver, Canada

Latest news

Stocktwits

Stocktradesmoon Oct 13, 4:56 PM
$ABCL ABOUT to SQUEEZE!!! $13’ssss!!!
0 replies
Stocktradesmoon Oct 13, 4:54 PM
$ABCL We ABOUT to GO from RED to SUPER..SUPER GREEN!!! 👀 $13’sss on the WAY!! Look 👀 at LEVEL II 🔥 buys!!!
0 replies
Stocktradesmoon Oct 13, 4:41 PM
$ABCL ABcellera 🔥 🔥
0 replies
Stocktradesmoon Oct 13, 4:33 PM
$ABCL BULLS are buying the Dip!! BUY ALL YOU CAN!!! Follow the SMART MONEY 💵!!! People starting to come back from LUNCH and LOADING up and ADDING to their Positions!! $12.50’-60sss NO BRAINER see at $13 this Afternoon!!! BOOM!!💥 🚨🚨 Major Catalysts in a few days. This is the time to GET IN!! 👀 You MAKE that CHOICE!! We ABOUT to SQUEEZE so fast to $13’ssss!!! CONSOLIDATION Done ✅ Remember, the Longer the base the BIGGER the BREAK-OUT!!! I DON’T Want to MISS OUT 200%-300% Move because of a few cents down!
0 replies
Stocktradesmoon Oct 13, 4:13 PM
$ABCL 🔥 ABcellera!!!
0 replies
Stocktradesmoon Oct 13, 3:45 PM
$ABCL STARTING in a few days 10/20-10/22! 👀🔥🚨🍾!!!
1 replies
DeMampCamp Oct 13, 3:44 PM
$ABCL We're doing a pretty good job at treading water while the markets are making some very big adjustments. Would love to see some news\updates from the company to give us a jolt. I want to know what ABCL688 will be for, would love to know managements plan for ABCL 635 phase 3, still waiting for phase 1 readout for ABCL575 too. Happy Tuesday everyone!
1 replies
Stocktradesmoon Oct 13, 3:15 PM
$ABCL $18 🔥 Let’s GO!!!
1 replies